Dihydrocodeine 30 mg is a prescription painkiller used in the UK to treat moderate to severe pain when simpler analgesics such as paracetamol or ibuprofen are not sufficient. It belongs to the opioid class of medicines, meaning it works by acting on opioid receptors in the brain and spinal cord to reduce the perception of pain.
In UK clinical practice, dihydrocodeine 30 mg is often used for acute pain (such as injury or post-operative pain) and sometimes for chronic pain conditions under specialist supervision. It is also sometimes combined with paracetamol in co-codamol formulations, although single-ingredient dihydrocodeine is prescribed when stronger opioid control is needed.
Clinical evidence shows that dihydrocodeine can provide effective short-term pain relief, but its use is generally limited due to the risks associated with opioids. These include drowsiness, constipation, nausea, and dizziness, which are common even at therapeutic doses.
A key concern in UK prescribing is the potential for dependence and tolerance with prolonged use. For this reason, dihydrocodeine is classified as a controlled drug (Class B) under UK law, meaning its prescribing is strictly regulated.
UK guidance recommends that dihydrocodeine should be used at the lowest effective dose for the shortest possible duration, and only when alternative pain relief options have not been effective. Patients are also advised to avoid alcohol and be cautious with activities requiring alertness, such as driving, while taking the medication.
👍 Conclusion
Dihydrocodeine 30 mg is an effective opioid painkiller used in the UK for moderate to severe pain. While it provides strong pain relief, its use is carefully controlled due to the risks of dependence and side effects, and it is intended mainly for short-term treatment under medical supervision.